1359257817622978561

Today at #TCTM21 Dr. Mitchell Horwitz of Duke University is presenting the full efficacy and safety results of the Phase 3 clinical study of our investigational cell therapy, omidubicel. Read more in our release: https://t.co/LKXdnXW8rF https://t.co/BQvKa3HmmL

Send us a message